BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23

• Press Releases

  Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk

  October 1, 2026

   · 

  14 min read
• Press Releases

  Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities

  October 1, 2026

   · 

  4 min read
• Press Releases

  Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development

  October 1, 2026

   · 

  8 min read
• Press Releases

  Hansa Biopharma Partners with Cradle to Advance AI-Driven Protein Design and Engineering

  October 1, 2026

   · 

  4 min read
• Press Releases

  Renew Biotechnologies Enters Collaboration to Evaluate NeuroLens® in Multiple Sclerosis and Related Neuroimmunologic Diseases

  October 1, 2026

   · 

  2 min read
• Press Releases

  New Senior Commercial Appointments at Neuromod

  October 1, 2026

   · 

  5 min read
• Press Releases

  Nanoscope Therapeutics Announces PMDA Acceptance and Priority Review of New Drug Application for MOGENRY® in Japan for the Treatment of Inherited Retinal Dystrophies

  October 1, 2026

   · 

  6 min read
• Press Releases

  Brogidirsen (NS-089/NCNP-02) 5-Year Clinical Trial Data for the Treatment of Duchenne Muscular Dystrophy Presented at 2026 World Muscle Society Congress

  October 1, 2026

   · 

  3 min read
• Press Releases

  Lilly’s oral GLP-1, Foundayo (orforglipron), was associated with significant reductions in predicted long-term risk of type 2 diabetes and cardiovascular disease

  October 1, 2026

   · 

  22 min read
• Press Releases

  HLS Therapeutics Announces Board of Directors Changes

  October 1, 2026

   · 

  5 min read